Completed
BVA-200 vs BVA-100 Validation Study
NCT06227819
- Conditions
- Anemia, Cardiovascular Diseases, Clotting Disorder, +33 more
- Locations
-
- Daxor Corporation Oak Ridge, Tennessee, United States